Jadedstone Clinical Research
Welcome,         Profile    Billing    Logout  
 1 Trial 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kumar, Mukesh
NCT05407389: Rollover Extension Clinical Trial To Evaluate The Long-Term Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With CKD IV Completing The US-APR2020-01 Study

Suspended
2/3
600
US
KT-301 (formerly US-APR2020)
Kibow Pharma
Chronic Kidney Disease stage4
12/25
03/26
NCT04913272: Clinical Trial To Evaluate Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With Chronic Kidney Disease Stage IV

Suspended
2
630
US
US-APR2020, Placebo
Kibow Pharma
Chronic Kidney Disease stage4
09/25
12/25
NCT04750252: Safety and Tolerability of StroMel™ in Subjects with Moderate to Severe Osteoarthritis of the Knee Joint

Not yet recruiting
1/2
20
US
StroMel
Akan Biosciences, LLC
Osteo Arthritis Knee
08/27
08/27
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kumar, Mukesh
NCT05407389: Rollover Extension Clinical Trial To Evaluate The Long-Term Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With CKD IV Completing The US-APR2020-01 Study

Suspended
2/3
600
US
KT-301 (formerly US-APR2020)
Kibow Pharma
Chronic Kidney Disease stage4
12/25
03/26
NCT04913272: Clinical Trial To Evaluate Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With Chronic Kidney Disease Stage IV

Suspended
2
630
US
US-APR2020, Placebo
Kibow Pharma
Chronic Kidney Disease stage4
09/25
12/25
NCT04750252: Safety and Tolerability of StroMel™ in Subjects with Moderate to Severe Osteoarthritis of the Knee Joint

Not yet recruiting
1/2
20
US
StroMel
Akan Biosciences, LLC
Osteo Arthritis Knee
08/27
08/27

Download Options